D-0857-2016 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0857-2016 was initiated by Pfizer Inc. on Apr 28, 2016 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found. The recall status is terminated (terminated Jul 26, 2017). Affected quantity: 68, 214 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 1, 2016
Initiation Date
Apr 28, 2016
Termination Date
Jul 26, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
68, 214 bottles

Product description

Zoloft (sertraline HCl) tablets, 100 mg*, 30 count bottles, Rx only, Distributed by Roerig, Division of Pfizer, Inc., NY NY 10017, NDC 0049-4910-30.

Reason for recall

Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: M25569, Exp 08/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0857-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0857-2016. Report a data issue: hello@regdatalab.com.